From: Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients
Model 1 | Model 2 | ||||
---|---|---|---|---|---|
Total pill burden (pills/day/patient) |
Pill burden from PBs (pills/day/patient) |
Total pill burden (pills/day/patient) |
Pill burden from PBs (pills/day/patient) | ||
Gender (male) |
β (P) |
0.097 0.040 | |||
Age (years) |
β (P) |
- 0.110 0.011 |
- 0.250 < 0.001 |
- 0.090 0.037 |
- 0.255 < 0.001 |
Dialysis vintage (years) |
β (P) |
0.290 < 0.001 |
0.175 < 0.001 |
0.220 < 0.001 |
0.145 0.003 |
DM (yes) |
β (P) |
0.135 0.003 |
0.141 0.001 | ||
Serum P (mg/dL) |
β (P) |
0.210 < 0.001 |
0.144 0.003 |
0.196 < 0.001 |
0.140 0.004 |
Oral calcimimetics (user) |
β (P) |
0.175 <0.001 |
0.106 0.032 | ||
IV calcimimetics (user) |
β (P) |
0.094 0.034 |